Dopamine increases L-type calcium current more in newborn than adult rabbit cardiomyocytes via D1 and β2 receptors

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 5, 2008, Pages

  Ding, Guoliang ^a   Wiegerinck, Rob F ^a   Shen, Ming ^a   Cojoc, Anca ^a   Zeidenweber, Carlo M ^a   Wagner, Mary B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adrenergic receptors; Development; Ventricle

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CALCIUM CHANNEL L TYPE; DOPAMINE; DOPAMINE 1 RECEPTOR; MESSENGER RNA; PROPRANOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CARDIOTONIC AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

ADOLESCENT; ANIMAL CELL; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CALCIUM CURRENT; CONTROLLED STUDY; HEART FAILURE; HEART MUSCLE CELL; HEART SURGERY; NEWBORN; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; AGE; ANIMAL; CELL MEMBRANE POTENTIAL; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; GENETICS; METABOLISM; SIGNAL TRANSDUCTION; UPREGULATION;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; CALCIUM; CALCIUM CHANNELS, L-TYPE; CARDIOTONIC AGENTS; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; MEMBRANE POTENTIALS; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; RABBITS; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 44949163664     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00993.2007     Document Type: Article

References (54)

1. Abrass IB, Davis JL, Scarpace PJ. Isoproterenol responsiveness and myocardial beta-adrenergic receptors in young and old rats. J Gerontol 37: 156-160, 1982.
2. Aguayo LG, Grossie J. Dopamine inhibits a sustained calcium current through activation of alpha adrenergic receptors and a GTP-binding protein in adult rat sympathetic neurons. J Pharmacol Exp Ther 269: 503-508, 1994.
3. Ando M, Takahashi Y, Suzuki N. Open heart surgery for small children without homologous blood transfusion by using remote pump head system. Ann Thorac Surg 78: 1717-1722, 2004.
4. Artman M, Mahony L, Teitel DF. Cardiovascular drug therapy. In: Neonatal Cardiology. New York: McGraw-Hill, 2002, p. 209-230.
5. Balijepalli RC, Foell JD, Hall DD, Hell JW, Kamp TJ. Localization of cardiac L-type Ca(2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation. Proc Natl Acad Sci USA 103: 7500-7505, 2006.
6. Bas A, Forsberg G, Hammarstrom S, Hammarstrom ML. Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde-3-phosphate- dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes. Scand J Immunol 59: 566-573, 2004.
7. Bradford M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
8. Brodde OE, Leifert FJ, Krehl HJ. Coexistence of beta 1- and beta 2-adrenoceptors in the rabbit heart: quantitative analysis of the regional distribution by (-)-3H-dihydroalprenolol binding. J Cardiovasc Pharmacol 4: 34-43, 1982.
9. Brodde OE, Vogelsang M, Broede A, Michel-Reher M, Beisenbusch-Schafer E, Hakim K, Zerkowski HR. Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy. J Cardiovasc Pharmacol 31: 585-594, 1998.
10. Brown L. Pharmacological responses to dopamine in isolated guinea-pig cardiovascular tissues: mechanisms of action. Arch Int Pharmacodyn Ther 308: 47-62, 1990.
11. Chen FM, Yamamura HI, Roeske WR. Ontogeny of mammalian myocardial beta-adrenergic receptors. Eur J Pharmacol 58: 255-264, 1979.
12. Collis L, Srivastava S, Coetzee WA, Artman M. Beta2 adrenergic agonists stimulate L-type calcium current independent of PKA in newborn rabbit ventricular myoctes. Am J Physiol Heart Circ Physiol 293: H2826-H2835, 2007.
13. Colthorpe KL, Curlewis JD. Localization and characterization of dopamine D1 receptors in sheep hypothalamus and striatum. J Neuroendocrinol 8: 561-568, 1996.
14. Deighton NM, Motomura S, Bals S, Zerkowski HR, Brodde OE. Characterization of the beta adrenoceptor subtype(s) mediating the positive inotropic effects of epinine, dopamine, dobutamine, denopamine and xamoterol in isolated human right atrium. J Pharmacol Exp Ther 262: 532-538, 1992.
15. Ding G, Qin Q, He N, Francis-David SC, Hou J, Liu J, Ricks E, Yang Q. Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferatoractivated receptor gamma. J Mol Cell Cardiol 43: 73-84, 2007.
16. Facchinetti F, Del GE, Furegato S, Passarotto M, Arcidiacono D, Leon A. Dopamine inhibits responses of astroglia-enriched cultures to lipopolysaccharide via a beta-adrenoreceptor-mediated mechanism. J Neuroimmunol 150: 29-36, 2004.
17. Feng ZP, Dryden WF, Gordon T. Postnatal development of adrenergic responsiveness in the rabbit heart. Can J Physiol Pharmacol 67: 883-889, 1989.
18. Fleg JL, Tzankoff SP, Lakatta EG. Age-related augmentation of plasma catecholamines during dynamic exercise in healthy males. J Appl Physiol 59: 1033-1039, 1985.
19. Gong H, Sun H, Koch WJ, Rau T, Eschenhagen T, Ravens U, Heubach JF, Adamson DL, Harding SE. Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart. Circulation 105: 2497-2503, 2002.
20. Habuchi Y, Lu LL, Komori T, Okamoto S, Nishimura M, Morikawa J, Yoshimura M. Does dopamine act on myocardial cells? Hypertens Res 18 Suppl 1: S157-S159, 1995.
21. 2+ channel function and expression in neonatal rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol 290: H2267-H2276, 2006.
22. 2+ channels in rat ventricular muscles. Br J Pharmacol 99: 334-339, 1990.
23. Kong MM, Hasbi A, Mattocks M, Fan T, O'Dowd BF, George SR. Regulation of D1 dopamine receptor trafficking and signaling by caveolin-1. Mol Pharmacol 72: 1157-1170, 2007.
24. Kuznetsov V, Pak E, Robinson RB, Steinberg SF. Beta 2-adrenergic receptor actions in neonatal and adult rat ventricular myocytes. Circ Res 76: 40-52, 1995.
25. Latifi S, Lidsky K, Blumer JL. Pharmacology of inotropic agents in infants and children. Prog Pediatr Cardiol 12: 57-79, 2000.
26. Lompre AM, Lambert F, Lakatta EG, Schwartz K. Expression of sarcoplasmic reticulum Ca(2+)-ATPase and calsequestrin genes in rat heart during ontogenic development and aging. Circ Res 69: 1380-1388, 1991.
27. Lundgren E, Terracio L, Allen DO, Borg TK. Modulation of beta-receptors as adult and neonatal cardiac myocytes progress into culture. In Vitro Cell Dev Biol 24: 28-34, 1988.
28. Matsumoto T, Ozono R, Sasaki N, Oshima T, Matsuura H, Kajiyama G, Carey RM, Kambe M. Type 1A dopamine receptor expression in the heart is not altered in spontaneously hypertensive rats. Am J Hypertens 13: 673-677, 2000.
29. Maurice JP, Shah AS, Kypson AP, Hata JA, White DC, Glower DD, Koch WJ. Molecular beta-adrenergic signaling abnormalities in failing rabbit hearts after infarction. Am J Physiol Heart Circ Physiol 276: H1853-H1860, 1999.
30. Mazzio E, Becker A, Soliman KF. Characterization of neurotransmitters and dopamine attenuation of inducible nitric oxide synthase in glioma cells. J Neuroimmunol 131: 70-82, 2002.
31. Mishra M, Wagner MB, Wang Y, Joyner RW, Kumar R. Expression of cGMP-dependent protein kinase in human atrium. J Mol Cell Cardiol 33: 1467-1476, 2001.
32. Moe TK, Ziliang J, Barathi A, Beuerman RW. Differential expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), beta actin and hypoxanthine phosphoribosyltransferase (HPRT) in postnatal rabbit sclera. Curr Eye Res 23: 44-50, 2001.
33. Molenaar P, Bartel S, Cochrane A, Vetter D, Jalali H, Pohlner P, Burrell K, Karczewski P, Krause EG, Kaumann A. Both beta(2)- and beta(1)-adrenergic receptors mediate hastened relaxation and phosphorylation of phospholamban and troponin I in ventricular myocardium of Fallot infants, consistent with selective coupling of beta(2)-adrenergic receptors to G(s)-protein. Circulation 102: 1814-1821, 2000.
34. Mugelli A, Ledda F, Mantelli L, Torrini M, Maccioni T. Studies on the positive inotropic effect of dopamine in the guinea-pig heart. Naunyn Schmiedebergs Arch Pharmacol 301: 49-55, 1977.
35. Namiki T, Joyner RW, Wagner MB. Developmental changes in time course of recovery from inactivation in L-type calcium currents of rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol 292: H295-H303, 2007.
36. O'Malley KL, Harmon S, Tang L, Todd RD. The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. New Biol 4: 137-146, 1992.
37. Osaka T, Joyner RW. Developmental changes in calcium currents of rabbit ventricular cells. Circ Res 68: 788-796, 1991.
38. Osaka T, Joyner RW. Developmental changes in the beta-adrenergic modulation of calcium currents in rabbit ventricular cells. Circ Res 70: 104-115, 1992.
39. Osaka T, Joyner RW, Kumar R. Postnatal decrease in muscarinic cholinergic influence on Ca2 currents of rabbit ventricular cells. Am J Physiol Heart Circ Physiol 264: H1916-H1925, 1993.
40. Ozono R, O'Connell DP, Vaughan C, Botkin SJ, Walk SF, Felder RA, Carey RM. Expression of the subtype 1A dopamine receptor in the rat heart. Hypertension 27: 693-703, 1996.
41. Ozono R, O'Connell DP, Wang ZQ, Moore AF, Sanada H, Felder RA, Carey RM. Localization of the dopamine D1 receptor protein in the human heart and kidney. Hypertension 30: 725-729, 1997.
42. Papp JG. Cardiac responses to drugs at the extremes of age. Therapie 46: 283-291, 1991.
43. Qu Y, Boutjdir M. Gene expression of SERCA2a and L- and T-type Ca channels during human heart development. Pediatr Res 50: 569-574, 2001.
44. Ricci A, Bronzetti E, Fedele F, Ferrante F, Zaccheo D, Amenta F. Pharmacological characterization and autoradiographic localization of a putative dopamine D4 receptor in the heart. J Auton Pharmacol 18: 115-121, 1998.
45. Roeske WR, Wildenthal K. Responsiveness to drugs and hormones in the murine model of cardiac ontogenesis. Pharmacol Ther 14: 55-66, 1981.
46. Tabbutt S, Helfaer MA, Nichols DC. Pharmacology of cardiovascular drugs. In: Critical Heart Disease in Infants and Children, edited by Nichols DC, Ungerleider RM, Spevak PJ, Greeley WJ, Cameron DE, Lappe DG, Wetzel RC. Philadelphia: Mosby Elsevier, 2006, p. 173-203.
47. Tipparaju SM, Kumar R, Wang Y, Joyner RW, Wagner MB. Developmental differences in L-type calcium current of human atrial myocytes. Am J Physiol Heart Circ Physiol 286: H1963-H1969, 2004.
48. Varriale P. Role of dopamine in congestive heart failure: a contemporary appraisal. Congest Heart Fail 5: 120-124, 1999.
49. Wang Y, Wagner MB, Joyner RW, Kumar R. cGMP-dependent protein kinase mediates stimulation of L-type calcium current by cGMP in rabbit atrial cells. Cardiovasc Res 48: 310-322, 2000.
50. Xiao RP, Tomhave ED, Wang DJ, Ji X, Boluyt MO, Cheng H, Lakatta EG, Koch WJ. Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J Clin Invest 101: 1273-1282, 1998.
51. Yao X, Parnot C, Deupi X, Ratnala VR, Swaminath G, Farrens D, Kobilka B. Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor. Nat Chem Biol 2: 417-422, 2006.
52. Yu P, Yang Z, Jones JE, Wang Z, Owens SA, Mueller SC, Felder RA, Jose PA. D1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells. Kidney Int 66: 2167-2180, 2004.
53. Zhang XF, Cooper DC, White FJ. Repeated cocaine treatment decreases whole-cell calcium current in rat nucleus accumbens neurons. J Pharmacol Exp Ther 301: 1119-1125, 2002.
54. 2+ current in single atrial and ventricular myocytes of the rat. Br J Pharmacol 121: 1247-1254, 1997.